Eithne01,
The treatment of chronic myeloid leukemia (CML) has changed significantly since the late 1990s, with the development and subsequent approval by the Food and Drug Administration of imatinib (in 2001), the first of a class of medications called tyrosine kinase inhibitors, which target the specific abnormality that causes CML.
Before that time, patients were treated with other therapy, including interferon and bone marrow transplant, and had very poor outcomes.
I saw a new retina specialist last week and he also mentioned a new drug that's in late clinical trials for retinal bleeding/abnormal vessels. If it's the same one your doctor mentioned, the brand name is Fovista.
His description of it was that it was an 'anti-platelet derived growth factor (PDGF)' drug targeted at the very tip of new blood vessels growing in the eye.
Are you currently on any medication like imatinib? The neutropenia can be due to your current medication. You can ask your hematologist for G-CSF injection if you have persistent neutropenia. Patients with CML are immunocompromised and can easily acquire infections. Neutropenia also puts a patient in an immunocompromised state.
For now, it is very important to prevent acquiring any infection. You should avoid crowded places and persons with ongoing infection.
Good luck.
Hi.
Chronic Myelogenous Leukemia (CML) is a blood disorder caused by an acquired genetic defect in the pleripotent stem cell. It has several phases: indolent chronic or stable phase, aggressive or advanced phase, and accelerated and blastic phase. The transition between phases may take years (on the average, 4 to 6 years from the stable phase to aggressive phase).
Average survival rates are generalizations, not applicable to a particular patient. The prognosis is relatively good. Newer techniques are being tried, including imatinib and stem cell transplantation.
All the best, and God Bless!
TY for the reply. Yes I was told and am thinking that its parasitc or allergy. I went to aruba in June but that wouldn't have an affect on me now, would it?
The platelets are where all the various growth factors(TGF-b, egf, pdgf, igf..) are located. Once the blood is separated the platelets get caught up in the Buffy coat(WBC's, older RBC's) via density seperation. Therefore the prp normally is red in color. I'm only letting you know because there are several prp's on the market now & I just want you to get the most 'bang for your buck'.
Best of luck with your issues, I hope they resolve soon.
My penis is not small, I don't think penis size reflects self worth, I don't rival any man for their penis size, neither I like women. Also, this is not a topic about "how to be happier with your current penis length".
I am asking in a medical sense, what are the changes an adult experience that prevent medicine from creating any surgery, procedure, or hormonal therapy that really works.
Therapy with corticosteroids is used for the treatment of most and additional therapy is available and dependent upon the type of HS. Newer medicines such as imatinib and mepolizumab are said to be promising. So, should your son have HS, there is reason to be optimistic regarding a positive response to currently available therapy.
You should request, of his doctor, an additional explanation for the tentative diagnosis of pre-hypertension.
Good luck.
Patients with hypereosinophilic syndrome should be tested for the presence of the FIP1L1-PDGRFA-mutatition in order to identify patients that could benefit from a treatment with a tyrosine kinase inhibitor such as Imatinib. At present, immunosuppression is still the treatment of first choice for Churg-Strauss syndrome. Novel treatment modalities for both diseases include immunomodulation with interferon alpha and biologics such as antibodies against interleukin 5.
personal communication) on cultured human dermal microvascular endothelial cells, as well as the chick chorioallantoic membrane and mouse matrigel models of angiogenesis. This anti-angiogenic effect of tetrac on multiple pro-angiogenic molecules further increases its attractiveness as a therapeutic agent."
Lay summary: Researchers are investigating the use of Tetrac as an anti-angiogenic agent.
PET CT SCAN mentioned no metabolically alive cells, As precaution I was put on Imatinib for last 4 months. LFT was normal for first 3 months, This month I have raised SGOT & SGPT LEVELS & also HBV Ag is positive ( Was Negative in test done before my Surgery).Should I continue on Imatinib or need to go for a second opinion. What is the course duration & Will this HBV ben cured.
Recommended
